Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Immunity Bio Biologics Licence Application to FDA

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Apr 01, 2022 7:48pm

162 Views

Post# 34569117

RE:RE:RE:Immunity Bio Biologics Licence Application to FDA

I find that the survival curves for Immunity bio data suggest continuous fall off with time. They are not like some where everyone who is going to be cured is cured and the relapsers have relapsed. It looks lke the % just keeps dropping off the further out you go.

From the 12 m mark, 50% of the remaining paitients fall off by 24m. Slide 12 of the Feb presentation.

<< Previous

Bullboard Posts

Next >>

Globex Mining: Unveiling Québec’s hidden gold and lithium treasures